Canton Strategic Holdings (CNTN) Return on Capital Employed (2022 - 2026)
Canton Strategic Holdings' (CNTN) quarterly Return on Capital Employed came in at 9.88% in Q1 2026, up 583685.0% YoY from N/an in Q1 2025, and down 27.86% on a QoQ basis from 7.73% in Q4 2025.
Canton Strategic Holdings (CNTN) Return on Capital Employed (2022 - 2026) Analysis & Trends
Canton Strategic Holdings (CNTN) has 5 years of Return on Capital Employed data on file, last reported at 9.88% in Q1 2026.
- Quarterly Return on Capital Employed rose 583685.0% year-over-year to 9.88% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.88% (up 583685.0% YoY) and the FY2025 annual result came in at 7.79%, up 24424.0% from the prior year.
- Return on Capital Employed retreated to 9.88% in Q1 2026, from 7.73% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 18004.79% in Q2 2025 to a low of 5846.74% in Q1 2025.
- A 5-year average of 557.17% and a median of 129.79% in 2024 frame the typical range for Return on Capital Employed.
- The widest YoY moves for Return on Capital Employed: up 1813458 bps in 2025, down 573424 bps in 2025.
- Tracing CNTN's Return on Capital Employed over 5 years: stood at 110.85% in 2022, then tumbled by 63 bps to 180.39% in 2023, then plunged by 232 bps to 598.32% in 2024, then jumped by 99 bps to 7.73% in 2025, then fell by 28 bps to 9.88% in 2026.
- The last three Return on Capital Employed figures came in at 9.88% (Q1 2026), 7.73% (Q4 2025), and 288.64% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.76% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.74% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -55.45% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.20% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 7.88% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 26.09% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -50.93% |
| 10 | Canton Strategic Holdings | 419.57 Mn | 419.57 Mn | - | -9.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.88% |
| Dec 31, 2025 | -7.73% |
| Sep 30, 2025 | -288.64% |
| Jun 30, 2025 | 18,004.79% |
| Mar 31, 2025 | -5,846.74% |
| Dec 31, 2024 | -598.32% |
| Sep 30, 2024 | -245.93% |
| Jun 30, 2024 | -129.79% |
| Mar 31, 2024 | -112.49% |
| Dec 31, 2023 | -180.39% |
| Sep 30, 2023 | -351.39% |
| Jun 30, 2023 | -286.64% |
| Mar 31, 2023 | -197.06% |
| Dec 31, 2022 | -110.85% |
| Sep 30, 2022 | -63.39% |
| Jun 30, 2022 | -36.45% |
| Mar 31, 2022 | -67.15% |